iShares Russell 1000

Most Recent

  • uploads///
    Company & Industry Overviews

    An Overview of Take-Two Interactive Software’s Foray into eSports

    The global eSports market is expected to reach $1 billion in 2017. Approximately one-third of the eSports fans in the United States participate in online amateur tournaments.

    By Adam Rogers
  • uploads///BBY Valuation
    Earnings Report

    Why Best Buy Expects Revenue to Fall Further in Fiscal 2017

    Best Buy (BBY) expects its revenue to keep falling in the first half of fiscal 2017, which ends on January 28, 2017, based on the current industry dynamics.

    By Sirisha Bhogaraju
  • uploads///Q All Other
    Earnings Report

    How Did Reynolds American’s ‘All Other’ Segment Perform in 4Q15?

    RAI’s increase in revenue was driven by the continued strong performance of Vuse Digital Vapor Cigarette in 4Q15.

    By Penny Morgan
  • uploads///Both Small and Large Caps Are Trading at Historical Valuations
    Macroeconomic Analysis

    Do Large Caps Offer More Value Relative to Small Caps?

    Large caps will be in a much better position to navigate through this period given their cash positions.

    By Russ Koesterich, CFA
  • uploads///Part  graph
    Basic Materials

    Why LYB’s Olefins and Polyolefins – EAI Revenue Fell in 2Q16

    In 2Q16, LyondellBasell’s (LYB) Olefins & Polyolefins – Europe, Asia, and International (or EAI) segment reported revenue of $2.7 billion.

    By Peter Neil
  • uploads///KO Margins
    Earnings Report

    Coca-Cola’s 4Q15 Operating Margin Rose on Productivity Measures

    Coca-Cola’s operating margin improved significantly to 15.2% in 4Q15 from 13.3% in the comparable quarter of the previous year.

    By Sirisha Bhogaraju
  • uploads///Net DEBT
    Miscellaneous

    Analyzing National Oilwell Varco’s Net Debt after 1Q17

    National Oilwell Varco’s (NOV) net debt increased 4% in 1Q17 over 1Q16. Its net debt amounted to ~$1.7 billion in 1Q17.

    By Alex Chamberlin
  • uploads///Series  A
    Company & Industry Overviews

    Behind Micron’s Product Enablement Plan for 3D XPoint

    Micron and Intel have developed 3D XPoint in a way that benefits from both DRAM (dynamic random access memory) and NAND (negative AND).

    By Puja Tayal
  • uploads///PepsiCo Revenue
    Earnings Report

    Can PepsiCo’s Revenue Rise after 3 Straight Quarters of Decline?

    PepsiCo’s revenue in 2Q15 fell 5.7% due to a 10 percentage point impact of currency headwinds. PepsiCo expects currency headwinds to have an 11 percentage point impact on net revenue growth in 3Q15.

    By Sirisha Bhogaraju
  • uploads///Graph
    Company & Industry Overviews

    Alnylam Pharmaceuticals: Developing Therapies for Hereditary ATTR Amyloidosis

    Alnylam Pharmaceuticals (ALNY) is currently developing three investigational therapies—Patisiran, Revusiran, and ALN-TTRsc02—for the treatment of patients with hereditary ATTR amyloidosis.

    By Margaret Patrick
  • uploads///RTD Coffee
    Macroeconomic Analysis

    Why Ready-to-Drink Coffee Is Gaining Popularity with US Consumers

    Coffee lovers in the United States are boosting ready-to-drink coffee volumes.

    By Sirisha Bhogaraju
  • uploads///Graph
    Company & Industry Overviews

    AbbVie Hopes to Commercialize Next-Generation HCV Regimen by 2017

    AbbVie (ABBV) plans to complete its Phase 3 registrational program for investigational next-generation Hepatitis C virus (or HCV) therapy by 2016.

    By Margaret Patrick
  • uploads///
    Company & Industry Overviews

    Tesla: Analyst Predicts Solid Future Demand for Model 3

    Wedbush Securities analyst Dan Ives expects Tesla Model 3 demand to remain “very strong into 2019 and beyond.”

    By Jitendra Parashar
  • uploads///lotus edge
    Company & Industry Overviews

    Boston Scientific’s Lotus Edge Valve System Gets Approval in Europe

    Boston Scientific (BSX) is consistently working towards gaining higher market share in the attractive TAVR (transcatheter aortic valve replacement) market in Europe.

    By Sarah Collins
  • uploads///JCP Earnings
    Earnings Report

    JCPenney’s Stock Rises by 14.7% on 4Q15 Earnings Beat

    JCPenney’s earnings were ahead of the consensus Wall Street analysts’ estimate of $0.21 per share.

    By Sirisha Bhogaraju
  • uploads///Valuation
    Earnings Report

    Can PepsiCo’s Valuation See Some Upward Revision in 2016?

    As of January 28, 2016, PepsiCo (PEP) was trading at a forward price-to-earnings ratio of 20.6x.

    By Sirisha Bhogaraju
  • uploads///GBS
    Company & Industry Overviews

    IBM is Pursuing Acquisitions to Push its Strategic Imperatives

    Despite IBM’s Strategic Imperatives’ double-digit growth, IBM has been unable to post any revenue growth in the last 15 consecutive quarters. As a result, IBM’s stock touched a five-year low in late 2015.

    By Anne Shields
  • uploads///Net Debt
    Company & Industry Overviews

    Analyzing National Oilwell Varco’s Debt—A 2% Year-over-Year Fall

    National Oilwell Varco’s (NOV) total debt decreased ~18% in 4Q16 over 4Q15. Its cash and marketable securities decreased 31% during the same period.

    By Alex Chamberlin
  • uploads///
    Company & Industry Overviews

    This Elon Musk Tweet Shows One Reason Why Investors Love Tesla

    Tesla has lost about 9.8% month-to-date as of December 27.

    By Jitendra Parashar
  • uploads///fffeafcbffefec
    Earnings Report

    What’s Really Driving Atmel’s Stock Volatility?

    Atmel has a PE (price-to-equity) ratio of 80.3, which is way higher than Intel’s (INTC) 12.9, Texas Instrument’s (TXN) 18.19, and Microchip’s (MCHP) 26.9.

    By Puja Tayal
  • uploads///Graph
    Company & Industry Overviews

    What Will Be a Key Driver of Biogen’s Future Valuations?

    Biogen’s investigational Alzheimer’s disease drug, aducanumab, is one of the four therapies accepted in the EMA’s Priority Medicines program (or PRIME).

    By Margaret Patrick
  • uploads///Net Debt
    Miscellaneous

    What’s Schlumberger’s Net Debt after 1Q17?

    Schlumberger’s (SLB) net debt rose 65% in 1Q17—compared to 1Q16. Its net debt was ~$11.7 billion in 1Q17.

    By Alex Chamberlin
  • uploads///REvenue and earnings
    Energy & Utilities

    Inside Baker Hughes’s Growth Drivers in 2Q17

    Baker Hughes’s (BHGE) North America segment saw 16.5% higher revenues from 2Q16 to 2Q17.

    By Alex Chamberlin
  • uploads///Part
    Earnings Report

    Under Armour: The ARMOURY and Its Wholesale Strategic Importance

    The ARMOURY stores will cater to the premium segment of the market. They’ll also feature UA product exclusives and occasional visits from star athletes.

    By Phalguni Soni
  • uploads///Seriea  A
    Earnings Report

    What Does Fairchild’s Cash Position Say about Its Future?

    In fiscal 2015, Fairchild’s cash from operating activities fell by 51% YoY to $94.4 million. That year, the company spent $96 million on share buybacks.

    By Puja Tayal
  • uploads///JCP Merchandise Mix
    Company & Industry Overviews

    JCPenney Brings Appliances Back to Stores after Over 3 Decades

    JCPenney (JCP) will be bringing a leading assortment of major appliances to 22 pilot stores effective February 1, 2016.

    By Sirisha Bhogaraju
  • uploads///tesla _
    Company & Industry Overviews

    Are Tesla Short-Sellers Enjoying Elon Musk’s Silence?

    December is proving to be underwhelming for Tesla investors (IWB).

    By Jitendra Parashar
  • uploads///Telecom Mobile Traffic in the US
    Company & Industry Overviews

    Sprint’s Positioning in the US Wireless Space

    Sprint’s chief financial officer Tarek Robbiati discussed this second reason for the company’s 50% discount promotion.

    By Ray Sheffer
  • uploads///ANR
    Earnings Report

    Analyst Recommendations for Kinder Morgan: ‘Buy’ or ‘Hold’?

    In this part of the series, we’ll look at what Wall Street analysts recommend for Kinder Morgan (KMI).

    By Kurt Gallon
  • uploads///Part
    Consumer

    The Lowe’s-Rona Transaction: Sizing Up the Potential Synergies

    Lowe’s (LOW) expects the Rona (RON.TO) transaction to be accretive to its earnings per share or EPS from the very first year after the acquisition.

    By Phalguni Soni
  • uploads///Macys sales growth trend
    Company & Industry Overviews

    Weak Sales: Specific to Macy’s or Other Department Stores, Too?

    Macy’s (M) has missed consensus Wall Street sales estimates in each of the first three quarters of fiscal 2015, which will end January 30, 2016.

    By Sirisha Bhogaraju
  • uploads///part
    Earnings Report

    Wireless Service and Equipment Revenues Decline for Sprint

    Sprint’s revenues also declined 3% on a quarter-over-quarter basis by $255 million due to lower revenues in the equipment and wireless revenue segments.

    By Adam Rogers
  • uploads///Stock Price and outlook
    Energy & Utilities

    What’s National Oilwell Varco’s Outlook for 4Q17?

    National Oilwell Varco’s (NOV) management has identified demand growth in hydraulic fracturing equipment, closed-loop drilling, downhole tools, and completion tools.

    By Alex Chamberlin
  • uploads///Part
    Earnings Report

    VF Corporation’s 1Q15 Margins Are Expected to Improve

    VF Corporation (VFC) expects margins to improve in 2015, coming in at 49.3% compared to 48.8% in 2014. Margins have been expanding over the past few quarters.

    By Phalguni Soni
  • uploads///Series  A
    Company & Industry Overviews

    Trouble Looms for Qualcomm’s Chipset Business

    For fiscal 3Q16, Qualcomm’s (QCOM) expects MSM shipments to be between 175 million–195 million units, the same guidance as reported for fiscal 2Q16.

    By Puja Tayal
  • uploads///us mkt dead money
    Financials

    Are We in a Bear Market? Jeffrey Gundlach Weighs In

    When asked about a bear market, Gundlach took the opportunity to present some numbers. Currently, he’s in capital preservation mode.

    By Surbhi Jain
  • uploads///bull
    Company & Industry Overviews

    Uber Closes above $45 for the First Time while Lyft Stock Rallies

    After closing above its May 10 IPO listing price of $45 for the first time yesterday, Uber (UBER) was up 4% today. Can the rally last?

    By Mike Sonnenberg
  • uploads///Part
    Consumer

    Soros Fund Management’s Top Buys in the Fourth Quarter

    George Soros added 2.026 million shares of the SPDR Select Sector Fund (XLF) to its portfolio during the fourth quarter, giving it a weight of 1.5% in the portfolio.

    By Anuradha Garg
  • uploads///electric car _
    Company & Industry Overviews

    Tesla’s Q4 Deliveries and Production Data: What to Expect

    Tesla (TSLA) has been one of the handful of positive-return-yielding stocks in the fourth quarter so far.

    By Jitendra Parashar
  • uploads///car _
    Company & Industry Overviews

    Elon Musk Smartly Retains Power while Meeting SEC Obligations

    Musk seems to have found ways to retain power while meeting the SEC’s obligatory measures at the same time. Let’s take a closer look.

    By Jitendra Parashar
  • uploads///amsterdam _
    Company & Industry Overviews

    Elon Musk Lists Rival Electric Vehicles on Twitter—NIO, GM, Ford

    Before Tesla, many automakers launched limited-production electric models only to discontinue them soon after.

    By Jitendra Parashar
  • uploads///Broker Recommendation
    Energy & Utilities

    What Wall Street Says about Weatherford International

    On December 26, 2017, 78% of the Wall Street analysts tracking Weatherford International rated it a “buy” or some equivalent.

    By Alex Chamberlin
  • uploads///Broker Recommendations
    Energy & Utilities

    Wall Street’s Call on Weatherford International

    In this article, we’ll look Wall Street’s call and target price for Weatherford International (WFT) on September 12.

    By Alex Chamberlin
  • uploads///Stock Price and Outlook
    Energy & Utilities

    National Oilwell Varco’s Outlook for 3Q17

    Does National Oilwell management see a recovery in 2017? National Oilwell Varco (NOV) management identified strong US onshore activity and weak offshore energy exploration and production activity as the drivers behind its changing revenue mix in 2Q17. In the company’s 2Q17 conference call, chairman and CEO Clay C. Williams stated that “much of our business […]

    By Alex Chamberlin
  • uploads///FCF
    Consumer

    Why Was Baker Hughes’s Free Cash Flow Negative in 2Q17?

    Baker Hughes’s (BHGE) CFO (cash from operating activities) remained negative in 2Q17, continuing its negative cash flow trend in 1Q17.

    By Alex Chamberlin
  • uploads///Stock Price and Outlook
    Earnings Report

    What Are NOV’s Challenges and Opportunities in 2Q17?

    National Oilwell Varco’s (NOV) management expressed concern over upstream energy companies’ lower capex spending, which is negative for the oilfield services companies.

    By Alex Chamberlin
  • uploads///Broker Recommendations
    Miscellaneous

    What’s Wall Street’s Take on Weatherford as of June 7?

    In this article, we’ll look Wall Street analysts’ recommendations for Weatherford International (WFT) as of June 7, 2017.

    By Alex Chamberlin
  • uploads///cvg highlights
    Earnings Report

    How Medtronic’s CVG Segment Performed in Fiscal 4Q17

    Medtronic (MDT) reported ~$7.9 billion in worldwide revenues in fiscal 4Q17.

    By Sarah Collins
  • uploads///resonate approval
    Company & Industry Overviews

    BSX’s Resonate ICD and CRT-D Defibrillators Get US Approval

    On May 9, 2017, Boston Scientific (BSX) announced the FDA approval of its Resonate family of products, including its ICD and CRT-D systems.

    By Sarah Collins
  • uploads///Stock Price and Outlook
    Earnings Report

    Will National Oilwell Varco’s Returns Rise after 1Q17?

    Let’s take a look at some of the projects that could affect National Oilwell Varco’s (NOV) returns going forward.

    By Alex Chamberlin
  • uploads///Stock Price and Outlook
    Company & Industry Overviews

    National Oilwell Varco’s Growth Prospects in 2017

    National Oilwell Varco’s (NOV) management expects upstream activity in North America’s shale plays to improve in 2017.

    By Alex Chamberlin
  • uploads///Broker Recommendations
    Miscellaneous

    Analysts’ Recommendations for Weatherford International

    On March 1, ~71% of the analysts tracking Weatherford International rated it as a “buy,” ~20% rated it as a “hold,” and the rest rated it as a “sell.”

    By Alex Chamberlin
  • uploads///A_Semiconductors_AMAT_Q profit margins estimate
    Company & Industry Overviews

    These Factors Could Improve AMAT’s Profitability in 2017

    For fiscal 1Q17, AMAT expects its non-GAAP (generally accepted accounting principles) gross margin to rise 43.8% from 43.7% in fiscal 4Q16.

    By Puja Tayal
  • uploads///Graph
    Company & Industry Overviews

    Can AbbVie’s Anti-Tau Therapeutics Help Late-Stage Alzheimer’s Patients?

    Unlike Biogen (BIIB) and Eli Lilly, who have focused their attention on amyloid-beta based therapeutics, AbbVie (ABBV) is reluctant to enter this field.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Clinical Trial Data Shows Efficacy of Elagolix to Treat Uterine Fibroids

    Together, AbbVie (ABBV) and Neurocrine Biosciences (NBIX) aim to develop Elagolix as a minimally invasive yet effective therapy for uterine fibroids

    By Margaret Patrick
  • uploads///cvg
    Earnings Report

    Understanding Medtronic’s Weak CVG Segment Performance in Fiscal 2Q17

    Of Medtronic’s ~$7.3 billion in worldwide revenues in fiscal 2Q17, ~$2.6 billion came from Medtronic’s CVG segment, representing ~35% of the company total.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    AnacorAcquisition Added Crisaborole to Pfizer’s Portfolio

    On June 24, 2016, Pfizer (PFE) announced that it had completed the acquisition of Anacor Pharmaceuticals for a total net value of $5.2 billion. The acquisition added crisaborole.

    By Margaret Patrick
  • uploads///Historical Valuation
    Company & Industry Overviews

    What’s National Oilwell Varco’s Historical Valuation?

    On September 30, 2016, National Oilwell Varco’s (NOV) share price was 10% higher compared to December 31, 2015.

    By Alex Chamberlin
  • uploads///Target Price
    Company & Industry Overviews

    National Oilwell Varco’s Growth Prospects in 4Q16 and 2017

    National Oilwell Varco’s (NOV) management expects most of the upstream recovery in North America to take place in 2H17.

    By Alex Chamberlin
  • uploads///Net Debt
    Company & Industry Overviews

    Is National Oilwell Varco’s Net Debt Falling?

    National Oilwell Varco’s (NOV) net debt (total debt less cash & marketable securities) fell 20% in 3Q15.

    By Alex Chamberlin
  • uploads///Graph
    Company & Industry Overviews

    How Do Amgen’s Valuation Multiples Compare to Its Peers’?

    Since January 2015, Amgen has traded at a premium to Gilead Sciences (GILD) but at a significant discount to peers Biogen (BIIB) and Celgene (CELG).

    By Margaret Patrick
  • uploads///Historical Rate of US Economic Growth
    Macroeconomic Analysis

    Bill Gross: Monetary Policy on Steady but Slow Path

    After the release of the FOMC’s November statement, Bill Gross said that monetary policy in the United States is steadily moving toward normalization, though its pace is slow.

    By David Ashworth
  • uploads///Graph
    Company & Industry Overviews

    Analysts’ Recommendations for Amgen and Its Peers in 2016

    In the first nine months of 2016, Amgen witnessed strong volume growth for its key products such as Xgeva, Prolia, Nplate, Vectibix, and Sensipar.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Talazoparib and Pidilizumab May Prove Complementary to Pfizer’s Existing Oncology Drugs

    Medivation has added its robust research pipeline with two promising investigational drugs, Talazoparib and Pidilizumab, to Pfizer’s oncology portfolio.

    By Margaret Patrick
  • uploads///valiant captivia
    Company & Industry Overviews

    New Data Affirm Benefits of Medtronic’s Valiant Captivia

    On September 20, 2016, Medtronic posted its new safety and efficacy data for its Valiant Captivia Thoracic Stent Graft System.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Bristol-Myers Squibb’s Role in the Multiple Myeloma Market

    Bristol-Myers Squibb’s and AbbVie’s multiple myeloma drug Empliciti, combined with Celgene’s Revlimid and dexamethasone, received approval from the FDA.

    By Margaret Patrick
  • uploads///part
    Basic Materials

    How PPG’s Valuations Compare to Its Peers

    As of August 26, 2016, PPG Industries was trading at a one-year forward PE multiple of 16.0x compared to Sherwin-Williams and Valspar at 21.20x and 20.30x, respectively.

    By Peter Neil
  • uploads///Graph
    Company & Industry Overviews

    How Late-Stage Asset Rova-T Could Become a Leading Therapy

    AbbVie (ABBV) expects to file a biologics license application for Rova-T as a third-line therapy for small cell lung cancer (or SCLC) in 2017.

    By Margaret Patrick
  • uploads///TJX International segments
    Company & Industry Overviews

    Did the Brexit Vote Impact TJX’s International Sales in Fiscal 2Q17?

    TJX Companies anticipates its TJX Canada segment to deliver same-store sales growth of 7%–8% in fiscal 2017 and sales of $3.1 billion–$3.2 billion.

    By Sirisha Bhogaraju
  • uploads///fdabeecfeedae
    Company & Industry Overviews

    Recommended Reading: Bernstein’s ‘Charts for the Beach’

    According to Richard Bernstein, the five charts in the recent edition of his newsletter are “five of our favorite charts that highlight what we think consensus is currently missing.”

    By David Ashworth
  • uploads///Graph
    Earnings Report

    Gilead’s Profit Margin Squeezed by Drop in Hepatitis C Drug Sales

    Gilead Sciences reported diluted earnings per share (or EPS) of about $3.08 in 2Q16, which is a year-over-year (or YoY) decline of 2.2%.

    By Margaret Patrick
  • uploads///Part  graph
    Basic Materials

    How Does APD Compare to Its Peers ahead of Fiscal 3Q16?

    As of July 22, 2016, Air Products and Chemicals (APD) was trading at a one-year forward PE multiple of 18.8x compared to its peers Praxair and FMC.

    By Peter Neil
  • uploads///Average Monthly Job Additions Have Decreased in
    Healthcare

    Why Even a Good Jobs Report Couldn’t Cause Yields to Rise

    We could see fewer jobs added going forward. If this trend continues, bond (AGG) (BND) yields could most likely stay low.

    By Russ Koesterich, CFA
  • uploads///The QE Program Led to a Full Fledged Asset Price Inflation
    Macroeconomic Analysis

    How Central Banks ‘Create’ Inflation

    A QE program doesn’t just create inflation; it causes asset prices to rise as well. After the financial crisis of 2008, the Fed resorted to an ultra-accommodative monetary policy.

    By Heather McArdle
  • uploads///MEDICAL DEVICE
    Earnings Report

    How Did JNJ’s Medical Devices Business Fare in 2Q16?

    Johnson & Johnson (JNJ) registered sales of approximately $6.4 billion in its Medical Devices business in 2Q16.

    By Sarah Collins
  • uploads///Inventory Q
    Consumer

    Beauty Companies Saw Mixed Inventory Levels in 1Q16

    Estée Lauder (EL) ended calendar 1Q16 with a 3.5% rise in inventory.

    By Penny Morgan
  • uploads///medical device business
    Earnings Report

    JNJ Is Restructuring Its Medical Devices Business: What of 2Q16?

    A robust pipeline and strong R&D (research and development) capabilities are expected to drive significant revenue growth for JNJ’s Medical Devices segment.

    By Sarah Collins
  • uploads///Series  A
    Company & Industry Overviews

    Will Restructuring Push Micron Back to Profitability?

    As part of its restructuring initiative, Micron would only focus on critical projects and cut 2,400 jobs.

    By Puja Tayal
  • uploads///Amazon Deal
    Company & Industry Overviews

    Can Amazon’s Re-Entry in the Smartphone Arena Pay Off?

    Amazon (AMZN), in order to keep its Prime membership popular, is offering two unlocked Android smartphones exclusively priced for Prime members.

    By Amit Singh
  • uploads///
    Company & Industry Overviews

    Which Gaming Franchises Are Expected to Drive Revenues for TTWO?

    Take-Two Interactive Software’s (TTWO) most successful franchise, Grand Theft Auto (or GTA), has sold over 235 million units worldwide.

    By Adam Rogers
  • uploads///Series  A
    Company & Industry Overviews

    Qualcomm Is Bringing LTE to Battery-Powered IoT Devices

    Recently, Qualcomm launched an LTE (long-term evolution) modems for battery-powered IoT devices to increase their communication range.

    By Puja Tayal
  • uploads///STZ Margins
    Consumer

    What Drove Constellation Brands’ Fiscal 1Q17 Margin Growth?

    In fiscal 1Q17, which ended on May 31, 2016, Constellation Brands’ gross margin increased significantly to 47.1% from 45.2% in fiscal 1Q16.

    By Sirisha Bhogaraju
  • uploads///rtg
    Company & Industry Overviews

    What Drives Medtronic’s Restorative Therapies Group’s Growth?

    Medtronic’s (MDT) Restorative Therapies Group (or RTG) segment, formed around seven years ago, has a strong market position today.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Why AbbVie Expects PTK7 to Enhance Its Oncology Capabilities

    Now in its phase-1 clinical trial, AbbVie’s PF-06647020, an ADC targeting protein kinase 7 could become a major therapy for advanced solid tumors.

    By Margaret Patrick
  • uploads///Series  A
    Company & Industry Overviews

    Intel to Leverage Its Product Portfolio to Tap IoT Growth

    IoT has a huge potential to create value for technology firms in the form of hardware, software, services, and integration.

    By Puja Tayal
  • uploads///Series  A
    Company & Industry Overviews

    What Is the Strategy behind Cypress-Broadcom’s All-Cash Deal?

    During Cypress’s fiscal 1Q16 earnings call, CEO Thurman John Rodgers explained that Broadcom offloaded the wireless IoT segment for two reasons.

    By Puja Tayal
  • uploads///Series  A
    Company & Industry Overviews

    What Is Analog Devices’ Acquisition Strategy?

    Analog Devices (ADI) has been using M&A (mergers and acquisitions) to rapidly expand its technology offerings and boost its revenue.

    By Puja Tayal
  • uploads///Series  A
    Company & Industry Overviews

    How Do NXP’s Cash and Debt Look after the Merger with Freescale?

    The company’s debt burden rose after it raised new debt to fund its $12 billion acquisition of Freescale. It also took on Freescale’s debt burden.

    By Puja Tayal
  • uploads///Series  A
    Company & Industry Overviews

    Inside Xilinx’s Lead over Altera in the 20- and 16-Nanometer Markets

    As Xilinx increases its share in the PLD market, a key will be its success in the long term is its competitive positioning compared to rival Altera.

    By Puja Tayal
  • uploads///Series  A
    Company & Industry Overviews

    Self-Driving Cars Could Mean Big Growth Opportunities for NXPI

    A key semicond trend is likely to intensify as the automotive market progresses toward self-driving cars.

    By Puja Tayal
  • uploads///Series  A
    Company & Industry Overviews

    Automotive: The Next Big Thing for Texas Instruments

    Texas Instruments (TXN) has increased its exposure in the automotive, industrial, and communications segments, which accounted for 64% of the company’s revenue in fiscal 1Q16.

    By Puja Tayal
  • uploads///Corporate Profits After Tax without IVA and CC Adjustment
    Company & Industry Overviews

    Corporate Profits Are Key for Richard Bernstein

    Richard Bernstein spoke with CNBC’s Michael Santoli about what drives stock markets. He noted that his firm employs a top-down, macro research approach.

    By David Ashworth
  • uploads///medsurg
    Company & Industry Overviews

    Understanding Boston Scientific’s MedSurg Segment

    Boston Scientific’s (BSX) MedSurg segment contributes around 33% to the company’s total revenues and is the company’s second-largest segment.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Celgene Continues to Develop New Multiple Myeloma Drugs

    Celgene has been working on its immunomodulatory backbone drugs to develop combination therapies for use in treating all lines of multiple myeloma.

    By Margaret Patrick
  • uploads///
    Earnings Report

    Why Did Analysts Lower Estimates for Papa John’s after 1Q16 Results?

    With same-store sales growth being lowered, it is expected that Papa John’s (PZZA) EPS will also be revised downward.

    By Rajiv Nanjapla
  • uploads///Graph
    Company & Industry Overviews

    How AbbVie Plans to Strengthen Its Position in Oncology

    On April 28, 2016, AbbVie (ABBV) announced its plans to acquire Stemcentrx. The deal is expected to be completed at a consideration of about $5.8 billion.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Behind OptumHealth’s and OptumInsight’s Strong Revenue Growth in 1Q16

    UnitedHealth Group’s healthcare delivery business, OptumHealth, managed to earn $4 billion revenues in 1Q16, which represents a YoY growth of about 22%.

    By Margaret Patrick
  • uploads///Series  A
    Earnings Report

    Why SanDisk Returned to Growth after a Year of Revenue Declines

    In fiscal 1Q16, SanDisk’s (SNDK) revenue rose 3% YoY, topping analysts’ estimate and its own guidance. This was the first growth after four consecutive quarters of decline.

    By Puja Tayal
  • uploads///Series  A
    Earnings Report

    Understanding Intel’s Strong Margins amid Slow Revenue Growth

    In fiscal 1Q16, Intel’s non-GAAP revenues rose by 8% YoY to $13.8 billion, missing the analyst estimate of $13.83 billion, which was a conservative one.

    By Puja Tayal
  • uploads///efbbdfbdfafeafebef
    Earnings Report

    Why Intel’s 1Q16 Earnings Suggest All Is Not Well

    Although Intel (INTC) reported revenue growth across all major business segments, it missed the analyst revenue estimate by $30 million.

    By Puja Tayal
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.